Avenue Therapeutics Inc (ATXI)

Avenue Therapeutics Inc Aktie (ATXI) Neueste Nachrichten

Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

GlobeNewswire Inc.

Avenue Therapeutics Announces Reverse Stock Split

GlobeNewswire Inc.

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

GlobeNewswire Inc.

Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire Inc.

Avenue Therapeutics Receives Positive Listing Determination from Nasdaq

GlobeNewswire Inc.

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

Benzinga

Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

GlobeNewswire Inc.

Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

GlobeNewswire Inc.

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

GlobeNewswire Inc.

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds

GlobeNewswire Inc.

Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket

Benzinga

Crude Oil Moves Lower; Walgreens Posts Upbeat Earnings

Benzinga

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Dow Surges 200 Points; US Services PMI Edges Higher In December

Benzinga

US Stocks Mixed; Jobless Claims Fall To 202,000

Benzinga

Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol

GlobeNewswire Inc.

Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

GlobeNewswire Inc.

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Benzinga

Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting

GlobeNewswire Inc.

Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

Benzinga

Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Benzinga

Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Benzinga

Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire Inc.